Leach Bryan sold $1.1M of IBTA
Leach Bryan (CEO AND PRESIDENT) sold 29,784 shares of Ibotta, Inc. (IBTA) at an average of $35.87 ($35.63–$37.44, $1.07M total) across 4 trades over 2026-08-17 to 2026-08-18 under a Rule 10b5-1 trading plan.
Ibotta, Inc.
No enriched coverage for $IBTA in the last 7 days.
Leach Bryan (CEO AND PRESIDENT) sold 29,784 shares of Ibotta, Inc. (IBTA) at an average of $35.87 ($35.63–$37.44, $1.07M total) across 4 trades over 2026-08-17 to 2026-08-18 under a Rule 10b5-1 trading plan.
Lehrman Thomas D sold 14,347 indirectly-held shares of Ibotta, Inc. (IBTA) at an average of $37.28 ($37.25–$37.86, $0.53M total) across 4 trades on 2026-08-13.
Lehrman Thomas D sold 15,926 shares of Ibotta, Inc. (IBTA) at an average of $37.37 ($37.19–$37.98, $0.60M total) across 2 trades on 2026-08-13.
Recent IBTA coverage spans insider activity and earnings.
In the last 30 days, IBTA insiders filed 28 SEC Form 4 transactions — no purchases and 28 sales ($4.6M). The most active reporter was Lehrman Thomas D with 12 filings. 57% of those filings were made under pre-arranged Rule 10b5-1 plans.
Minor negative signal as the CEO offloaded over $1M of stock, but the sale was pre‑arranged and size is modest.
This is an insider sale, not a company fundamental update. It may slightly affect sentiment, but it is unlikely to change near-term valuation on its own.
This is a routine insider sale disclosure with no stated 10b5-1 plan, but it does not provide new fundamentals or guidance.
This is an insider sale, not a company disclosure. It may slightly affect sentiment, but it does not change fundamentals by itself.
This is a routine insider sale with no 10b5-1 plan disclosed, but it does not by itself change fundamentals.
alphai scores every news story that mentions IBTA with an AI model for sentiment and relevance, and aggregates insider trades from Ibotta, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Leach Bryan (CEO AND PRESIDENT) sold 29,784 shares of Ibotta, Inc. (IBTA) at an average of $35.87 ($35.63–$37.44, $1.07M total) across 4 trades over 2026-08-17 to 2026-08-18 under a Rule 10b5-1 trading plan.
1 min readLehrman Thomas D sold 14,347 indirectly-held shares of Ibotta, Inc. (IBTA) at an average of $37.28 ($37.25–$37.86, $0.53M total) across 4 trades on 2026-08-13.
1 min readLehrman Thomas D sold 15,926 shares of Ibotta, Inc. (IBTA) at an average of $37.37 ($37.19–$37.98, $0.60M total) across 2 trades on 2026-08-13.
1 min readLehrman Thomas D sold 27,715 indirectly-held shares of Ibotta, Inc. (IBTA) at an average of $36.18 ($36.08–$36.22, $1.00M total) across 4 trades over 2026-08-11 to 2026-08-12.
2 min readLehrman Thomas D sold 14,692 shares of Ibotta, Inc. (IBTA) at an average of $35.88 ($35.73–$36.19, $0.53M total) across 2 trades over 2026-08-11 to 2026-08-12.
1 min readIbotta (IBTA) reported Q2 2026 revenue of $88.9 million, up 3% year over year, and adjusted EBITDA of $16.5 million. Third-party redemption revenue rose 27% to $61.5 million as the company shifted users to its publisher network. Q3 revenue guidance is $86 million to $90 million. Ibotta also said it added 11,500 7-Eleven locations via a partnership.
6 min readLeach Bryan (CEO AND PRESIDENT) sold 22,756 indirectly-held shares of Ibotta, Inc. (IBTA) at an average of $36.14 ($35.66–$37.41, $0.82M total) across 6 trades on 2026-08-04 under a Rule 10b5-1 trading plan.
2 min readLeach Bryan (CEO AND PRESIDENT) sold 72,274 shares of Ibotta, Inc. (IBTA) at an average of $33.69 ($24.39–$37.41, $2.43M total) across 5 trades over 2026-08-03 to 2026-08-04 under a Rule 10b5-1 trading plan.
2 min readU.S. stocks rose mid-session, with the Nasdaq up 2.22% and the S&P 500 up 1.64%. McDonald’s (NYSE:MCD) reported Q2 adjusted EPS of $3.38, above $3.32 estimates, and sales of $7.099B versus $7.128B expected. Oil fell 5.3% to $76.09 and gold rose 1.4% to $4,147.40.
3 min readIbotta, Inc. (IBTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Ibotta Reports Second Quarter 2026 Financial Results Ibotta’s second quarter financial results exceeded the upper end of the guidance range for both revenue and adjusted EBITDA Revenue grew by 3% year-over-year to $88.9 million Redemption revenue grew by 10% year-over-year to $80
6 min read